CRVS
Price
$10.65
Change
+$0.60 (+5.97%)
Updated
Oct 22 closing price
Capitalization
895.89M
12 days until earnings call
Intraday BUY SELL Signals
OVID
Price
$2.37
Change
-$0.10 (-4.05%)
Updated
Oct 22 closing price
Capitalization
462.86M
20 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRVS vs OVID

CRVS vs OVID Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CRVS vs. OVID commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRVS is a Buy and OVID is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CRVS with price predictions
Oct 22, 2026

CRVS's RSI Oscillator ascending out of oversold territory

The RSI Oscillator for CRVS moved out of oversold territory on October 19, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 39 similar instances when the indicator left oversold territory. In 34 of the 39 cases the stock moved higher. This puts the odds of a move higher at 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on CRVS as a result. In 75 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.

The Moving Average Convergence Divergence (MACD) for CRVS just turned positive on October 20, 2026. Looking at past instances where CRVS's MACD turned positive, the stock continued to rise in 35 of 42 cases over the following month. The odds of a continued upward trend are 83%.

Following a +7.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRVS advanced for three days, in 202 of 249 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

CRVS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 50-day moving average for CRVS moved below the 200-day moving average on September 21, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRVS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

The Aroon Indicator for CRVS entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.976) is normal, around the industry mean (2.973). P/E Ratio (-16.641) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. CRVS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRVS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for OVID with price predictions
Oct 22, 2026

OVID in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 13, 2026

OVID may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 33 of 38 cases where OVID's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where OVID's RSI Oscillator exited the oversold zone, 20 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 52 of 60 cases where OVID's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.

The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on OVID as a result. In 77 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

The Moving Average Convergence Divergence (MACD) for OVID just turned positive on October 21, 2026. Looking at past instances where OVID's MACD turned positive, the stock continued to rise in 41 of 54 cases over the following month. The odds of a continued upward trend are 76%.

Following a +13.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where OVID advanced for three days, in 207 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

Bearish Trend Analysis

OVID moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for OVID crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OVID declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for OVID entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.205) is normal, around the industry mean (2.973). P/E Ratio (-11.286) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (204.082) is also within normal values, averaging (438.009).

The Tickeron PE Growth Rating for this company is 44 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. OVID’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OVID’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
CRVS vs OVID: Fundamental Ratings
CRVS
OVID
OUTLOOK RATING
1..100
5518
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
18
Undervalued
PROFIT vs RISK RATING
1..100
83100
SMR RATING
1..100
9796
PRICE GROWTH RATING
1..100
6448
P/E GROWTH RATING
1..100
1844
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRVS's Valuation (11) in the Pharmaceuticals Major industry is in the same range as OVID (18). This means that CRVS’s stock grew similarly to OVID’s over the last 12 months.

CRVS's Profit vs Risk Rating (83) in the Pharmaceuticals Major industry is in the same range as OVID (100). This means that CRVS’s stock grew similarly to OVID’s over the last 12 months.

OVID's SMR Rating (96) in the Pharmaceuticals Major industry is in the same range as CRVS (97). This means that OVID’s stock grew similarly to CRVS’s over the last 12 months.

OVID's Price Growth Rating (48) in the Pharmaceuticals Major industry is in the same range as CRVS (64). This means that OVID’s stock grew similarly to CRVS’s over the last 12 months.

CRVS's P/E Growth Rating (18) in the Pharmaceuticals Major industry is in the same range as OVID (44). This means that CRVS’s stock grew similarly to OVID’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRVSOVID
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
88%
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
87%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (CRVS: $10.05 vs. OVID: $2.47)
Brand notoriety: CRVS and OVID are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRVS: 74% vs. OVID: 253%
Market capitalization -- CRVS: $895.89M vs. OVID: $462.86M
CRVS [@Biotechnology] is valued at $895.89M. OVID’s [@Biotechnology] market capitalization is $462.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRVS’s FA Score shows that 2 FA rating(s) are green while OVID’s FA Score has 1 green FA rating(s).

  • CRVS’s FA Score: 2 green, 3 red.
  • OVID’s FA Score: 1 green, 4 red.
According to our system of comparison, both CRVS and OVID are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRVS’s TA Score shows that 5 TA indicator(s) are bullish while OVID’s TA Score has 6 bullish TA indicator(s).

  • CRVS’s TA Score: 5 bullish, 3 bearish.
  • OVID’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both CRVS and OVID are a good buy in the short-term.

Price Growth

CRVS (@Biotechnology) experienced а +7.14% price change this week, while OVID (@Biotechnology) price change was +12.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.

Reported Earning Dates

CRVS is expected to report earnings on Nov 03, 2026.

OVID is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CRVS
Daily Signal:
Gain/Loss:
OVID
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

CRVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVS has been loosely correlated with ACRS. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if CRVS jumps, then ACRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVS
1D Price
Change %
CRVS100%
+5.97%
ACRS - CRVS
64%
Loosely correlated
+0.52%
RZLT - CRVS
42%
Loosely correlated
+4.32%
IMNM - CRVS
37%
Loosely correlated
+1.44%
AMLX - CRVS
36%
Loosely correlated
-1.58%
OVID - CRVS
35%
Loosely correlated
-4.05%
More

OVID and

Correlation & Price change

A.I.dvisor indicates that over the last year, OVID has been loosely correlated with KURA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if OVID jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OVID
1D Price
Change %
OVID100%
-4.05%
KURA - OVID
43%
Loosely correlated
-0.20%
CLDX - OVID
42%
Loosely correlated
-1.36%
SANA - OVID
40%
Loosely correlated
+0.85%
SLDB - OVID
39%
Loosely correlated
-3.43%
EDIT - OVID
39%
Loosely correlated
-0.80%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DTSS0.610.05
+8.50%
Datasea Intelligent Technology Ltd.
CARE30.700.33
+1.09%
Carter Bankshares
SBS6.27-0.05
-0.79%
Cia Saneamento Basico De Sao Paulo Spons
HURC21.03-0.34
-1.61%
Hurco Companies
TLX9.54-0.49
-4.89%
Telix Pharmaceuticals Ltd.